Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 98 tweets from 84 users, with an upper bound of 326,203 followers.

RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…

RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…

RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…

RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 94 additional tweets.